Table 3. Secondary outcomes for e-Care participants who completed the follow-up visit, n=90.
| Control | Web-dietitian | |||
|---|---|---|---|---|
|
| ||||
| M (95% CI) |
M (95% CI) |
M difference between groups (95% CI) |
P- value |
|
|
| ||||
| Patients completing follow-up visit | 46 | 44 | ||
|
| ||||
| Change from baseline | ||||
| HBA1c | 0.1 (−0.0, 0.1) | −0.0 (−0.1, 0.1) |
−0.1 (−0.2, 0.0) |
0.11 |
| Fasting blood sugar | −1.0 (−3.9, 1.8) |
−0.7 (−3.3, 1.9) |
0.3 (−3.5, 4.2) | 0.86 |
| Total cholesterol | −1.8 (−11.4, 7.9) |
−5.7 (−13.0, 1.7) |
−3.9 (−16.1, 8.2) |
0.52 |
| LDL cholesterol | −5.2 (−11.6, 1.2) |
−7.0 (−14.0, 0.0) |
−1.8 (−11.3, 7.7) |
0.71 |
| HDL cholesterol | −0.3 (−2.8, 2.1) |
1.5 (−0.4, 3.5) | 1.9 (−1.2, 5.0) | 0.24 |
| Fruits and vegetables, number of servings |
0.0 (−0.5, 0.6) | 2.3 (1.4, 3.2) | 2.3 (1.2, 3.3) | <0.01 |
| Hypertension medication classes, number of classes |
0.1 (0.0, 0.4) | 0.4 (0.1, 0.7) | 0.2 (−0.1, 0.5) | 0.16 |
| Hypertension medication adherence b,c |
−0.2 (−0.8, 0.3) |
−0.1 (−0.7, 0.5) |
0.1 (−0.7, 0.9) | 0.79 |
| Satisfaction with hypertension care (0–10 scale) |
−0.5 (−1.1, 0.2) |
1.3 (0.4, 2.1) | 1.7 (0.7, 2.7) | <0.01 |
| Obesity and weight loss quality of lifea |
2.5 (−0.4, 5.3) | 5.5 (2.7, 8.3) | 3.0 (−1.0, 7.1) | 0.14 |
| Patient assessment of chronic illness care |
||||
| Overall score | −0.1 (−0.5, 0.2) |
2.0 (1.6, 2.3) | 2.1 (1.6, 2.6) | <0.01 |
| Patient activation/self-efficacy | −0.4 (−0.8, 0.0) |
2.1 (1.7, 2.6) | 2.5 (1.9, 3.1) | <0.01 |
| Delivery system/practice design | −0.3 (−0.7, 0.2) |
2.0 (1.5, 2.5) | 2.3 (1.6, 2.9) | <0.01 |
| Goal setting/tailoring | −0.1 (−0.6, 0.3) |
2.1 (1.7, 2.5) | 2.3 (1.7, 2.8) | <0.01 |
| Problem solving/contextual | −0.3 (−0.6, 0.1) |
2.0 (1.6, 2.4) | 2.2 (1.7, 2.8) | <0.01 |
| Follow-up/coordination | −0.1 (−0.4, 0.2) |
1.6 (1.2, 2.0) | 1.7 (1.2, 2.2) | <0.01 |
|
| ||||
| Proportion at follow-up | % (95% CI) | % (95% CI) | RR (95% CI) | |
| Taking any hypertension medications |
52.2 (37.7, 66.6) |
63.6 (49.4, 77.9) |
1.22 (0.85, 1.74) |
0.27 |
| Hypertension medication intensificationb |
41.7 (21.9, 61.4) |
55.2 (37.1, 73.3) |
1.32 (0.74, 2.36) |
0.34 |
| Physical activity, often work up a sweat |
20.5 (8.5, 32.4) |
27.9 (14.5, 41.3) |
1.36 (0.64, 2.90) |
0.42 |
Range=1–10, with higher numbers representing better self-reported quality.
Intensification and adherence not defined for patients not taking hypertension medications.
Morisky self-reported hypertension medication adherence (range=0–8, with higher scores indicating worse adherence).
HBAlc, hemoglobin A1c; HDL, high-density lipoprotein; LDL, low-density lipoprotein; RR, relative risk